$Bluejay Diagnostics(BJDX.US)$ IMMEDIATE RELEASE Date: December 27, 2023 Bluejay Diagnostics, Inc. Announces Initiation of Multicenter Clinical Study Evaluating Symphony IL-6 in Sepsis Patients (SYMON Study) This Study performs unique rapid on-site measurements of interleukin-6 (IL-6) and positions Company to move forward with multiple initiatives. ACTON, Mass., Dec 27, 2023 – Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company...
2
举报
Lax13 :
Additional drops, what do you think is going on here?
$Bluejay Diagnostics(BJDX.US)$Bluejay Diagnostics, Inc. Announces Initiation of Multicenter Clinical Study Evaluating Symphony IL-6 in Sepsis Patients (SYMON Study) 2 MINUTES AGO, 9:00 AM EST VIA GLOBENEWSWIRE
$Bluejay Diagnostics(BJDX.US)$This is how the hedgies help us lose our money. I’m pretty sure they have more powerful systems than the pentagon. They are the scum of this earth and this bullshit must stop. They’re effing with people like my parents retirement accounts. Nobody should be allowed to manipulate any stock!$AMC院线(AMC.US)$
5
3
举报
MuscMoo :
yeah, destroyers of medical companies..... lower than low
rennymc楼主MuscMoo:
Right?! Bluejay has an amazing product that could cut down on wait times in hospitals and doctor’s offices by half, or more. Why do these scumbags have every ticker rigged? It’s infuriating. Happy to you, my friend!
$Bluejay Diagnostics(BJDX.US)$reported quarterly losses of $(2.08) per share. This is a 30.67 percent increase over losses of $(3.00) per share from the same period last year.
Bluejay Diagnostics股票讨论区
IMMEDIATE RELEASE
Date: December 27, 2023
Bluejay Diagnostics, Inc. Announces Initiation of Multicenter Clinical Study Evaluating
Symphony IL-6 in Sepsis Patients (SYMON Study)
This Study performs unique rapid on-site measurements of interleukin-6 (IL-6) and positions Company to move forward with multiple initiatives.
ACTON, Mass., Dec 27, 2023 – Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company...
2 MINUTES AGO, 9:00 AM EST
VIA GLOBENEWSWIRE
暂无评论